|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
30
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
This single-center, open-label, phase II trial evaluated the bortezomib, pegylated liposomal doxorubicin (PLD), and dexamethasone combination regimen (VDD) as initial treatment for patients with newly diagnosed multiple myeloma (MM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AhmedAsraA,
pubmed-author:Al-ZoubiAmmarA,
pubmed-author:BraunThomasT,
pubmed-author:BrozoChristineC,
pubmed-author:CampagnaroEricaE,
pubmed-author:JakubowiakAndrzej JAJ,
pubmed-author:KaminskiMark SMS,
pubmed-author:KendallTaraT,
pubmed-author:KhaledYasserY,
pubmed-author:MineishiShinS,
pubmed-author:TalpazMosheM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5015-22
|
|
pubmed:meshHeading |
pubmed-meshheading:19738129-Adult,
pubmed-meshheading:19738129-Aged,
pubmed-meshheading:19738129-Aged, 80 and over,
pubmed-meshheading:19738129-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19738129-Boronic Acids,
pubmed-meshheading:19738129-Dexamethasone,
pubmed-meshheading:19738129-Doxorubicin,
pubmed-meshheading:19738129-Female,
pubmed-meshheading:19738129-Humans,
pubmed-meshheading:19738129-Male,
pubmed-meshheading:19738129-Middle Aged,
pubmed-meshheading:19738129-Multiple Myeloma,
pubmed-meshheading:19738129-Polyethylene Glycols,
pubmed-meshheading:19738129-Pyrazines,
pubmed-meshheading:19738129-Stem Cell Transplantation,
pubmed-meshheading:19738129-Survival Analysis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.
|
|
pubmed:affiliation |
Comprehensive Cancer Center, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI 48109-5936, USA. ajakubow@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
